Latest Weather Blog
FDA says pause in use of J&J vaccine to investigate clots will likely last 'matter of days'
WASHINGTON — The Food and Drug Administration says it expects a short pause of Johnson & Johnson vaccines while regulators investigate reports of potentially dangerous clots in a small number of patients.
Dr. Janet Woodcock, the agency’s acting commissioner, says, “We expect it to be a matter of days for this pause.”
The U.S. FDA and the Center for Disease Control and Prevention recommended the pause Tuesday to investigate unusual clots in six women that occurred 6 to 13 days after vaccination with the J&J vaccine. The clots occurred in veins that drain blood from the brain and occurred together with low platelets. All cases were in women between the ages of 18 to 48.
Nearly 7 million J&J doses have been administered in the U.S., almost all without serious side effects.
Regulators say they want to educate patients and medical professionals about spotting and treating the clots. The clots were observed along with reduced platelet counts, making the usual treatment for blood clots, the blood thinner heparin, potentially “dangerous.”
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Pay raises for EBR educators a hot topic in heated town hall...
Roofing company losing business over name confusion
Bill creating task force to study high-speed police chases passes in House,...
United Cajun Navy explains why agencies suspended search for missing U-High grad
Narcisse advances in Broward County Schools superintendent search
LSU, Tulane to meet in first round of Baton Rouge Regional as...
LSU president reminisces during team trip to DC
Southern baseball sweeps Arkansas-Pine Bluff to finish out regular season
A candid conversation with Kim Mulkey - Watch the half-hour special on...
Channel 2's Best Bet$: NBA Playoffs